Latest Headlines

  1. Lucira Health Announces FDA Authorization Of Combination COVID-19 & Flu Test At Point-Of-Care 11/22/2022

    Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health" or "Lucira"), a medical technology company, announced today that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for its Lucira COVID-19 & Flu Test, for point-of-care use.

  2. Biological Dynamics Collaborates On Clinical Utility Studies To Examine The Impact Of Its Early Pancreatic Cancer Detection Assay 11/22/2022
  3. Sense And R-Biopharm Nederland B.V. Agree To Distribute Rapid, Instrument-Free Molecular COVID-19 Test In The Netherlands, Belgium, And Luxembourg 11/22/2022

    Global molecular diagnostics innovator Sense Biodetection (Sense) today announced it has entered into a strategic agreement with R-Biopharm Nederland B.V. for the non-exclusive distribution in the Netherlands, Belgium, and Luxembourg of Sense’s Veros instrument-free, point-of-care molecular testing platform.

  4. Cold Spring Harbor Laboratory Licenses Epistemic AI Research Intelligence Platform 11/21/2022

    Epistemic AI (EAI) is pleased to announce that the Cold Spring Harbor Laboratory (CSHL) has licensed its Research Intelligence platform.

  5. Castle Biosciences Receives Accreditation From The College Of American Pathologists For Its Pittsburgh Clinical Laboratory 11/21/2022

    Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, today announced that the Accreditation Committee of the College of American Pathologists (CAP) has accredited its clinical laboratory facility in Pittsburgh.

  6. Novel AI Blood Test Detects Liver Cancer 11/18/2022

    A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study of 724 people.

  7. Millstone Medical Outsourcing Completes Acquisition Of MycoScience 11/17/2022

    Millstone Medical Outsourcing, the industry's leading partner of choice for medical manufacturers' post-manufacturing and aftermarket services, announces its completed acquisition of MycoScience, on November 14, 2022.

  8. Pathnostics Announces Opening Of New Facility In Lake Mary Florida And Expansion Of Its Irvine California Laboratory And Headquarters 11/17/2022

    Pathnostics, a leading precision diagnostic testing and development company, today announced the broadening of its diagnostic laboratory capabilities with the opening of its third lab, located in Lake Mary, Florida, and expansion of its Irvine, California-based laboratory and headquarters.

  9. QNTM Labs Closes Series A Led By Intrinsic Capital Partners To Reinvent Pharmaceutical Lab Testing On A Global Scale 11/17/2022

    QNTM Labs, a pharmaceutical laboratory based in Denmark, is pioneering the development of analytical methods for both general pharmaceuticals and cannabinoid-based products through advanced testing, research, and development.

  10. HealthTrackRx Opens Louisville Area Lab To Deliver Next-Morning PCR Results Nationwide 11/17/2022

    HealthTrackRx, the nation's premier PCR diagnostic testing company, today announced the opening of its latest high-throughput lab in Clarksville, IN. The state-of-the-art facility, just across the river from Worldport, UPS's global air hub in Louisville, KY, will help healthcare providers treat patients faster with lab results by the next morning.